Clinical Trials on PI-RADS 3 Prostate Lesion

Total 23 results

SimonMed Imaging
Blue Earth Diagnostics

Not yet recruiting

POSLUMA PET Imaging for PI-RADS 3 Prostate Lesions (PRISM)

Prostate Cancer | PI-RADS 3 Prostate Lesion

United States
Jules Bordet Institute

Recruiting

The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA) (PANDORA)

Multiparametric MRI | Lesion PI-RADS 3

Belgium
University of California, Irvine

Withdrawn

Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor Imaging

Prostate Lesions

United States
Women's Hospital School Of Medicine Zhejiang University
Tongji Hospital; Wuhan Central Hospital

Recruiting

Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions

Cervical Intraepithelial Neoplasia Grade 2/3 | Cervical Lesion

China
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates

Prostate Cancer With at Least One Bone Lesion in Patients Receiving Hormonal Therapy and Treatment With Bisphosphonates is Indicated

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe